9:45am ET
Health and Healthcare
Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market
Pfizer and BioNTech stocks both exploded on Monday after these companies provided an update on their coronavirus vaccine.
Companies
/Healthcare
Pfizer Inc
$28.41
▲ $0.23 (+0.82%) today
Markets closed · 4:02am ET
PFE Coverage
Page 26
7:01pm ET
Health and Healthcare
Did Regeneron Just Revive Hopes About Beating COVID-19?
The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in 2020. With cases rising rapidly in the United States and in Europe,…
8:56am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, Caterpillar, Corning, DexCom, Enphase, First Solar, Invesco, 3M, Microsoft, Pfizer, Wynn and More
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Caterpillar, Corning, DexCom, Enphase Energy, First Solar, Invesco, 3M, Microsoft, Pfizer and Wynn Resorts.
10:49am ET
Health and Healthcare
Do Merck and Pfizer Earnings Signal a Pullback in Health Care?
Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday, and investors were not thrilled about this quarter for these two pharmaceutical giants.
6:10am ET
Investing
Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week
This week will be perhaps the biggest week of earnings season, with many major names reporting, including Amazon, Facebook, Ford and Starbucks.
10:46am ET
Health and Healthcare
What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?
While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s CEO has provided an update on their COVID-19 vaccine.
1:28pm ET
Health and Healthcare
Are President Trump’s COVID-19 Drugs the Real Winners in the Race?
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United States.…
11:58am ET
Health and Healthcare
Where We Stand on a Vaccine After Trump Catches COVID-19
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of where we stand with a coronavirus vaccine.
7:42am ET
Health and Healthcare
4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?
These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that won't also have huge product lines and robust pipelines with future drug…
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More
Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service and WPX Energy.
10:48am ET
Investing
The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals
The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of a Phase 3 trial.
9:26am ET
Health and Healthcare
This Week in Coronavirus News
As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple of weeks, firms working toward this goal have taken steps forward and…
7:27pm ET
Health and Healthcare
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval
America and the rest of the world is getting ready for a vaccine that will help protect public health against the COVID-19 pandemic. The societal impact of the coronavirus has changed many…
8:46am ET
Health and Healthcare
3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way
Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but none are approved yet.
8:50am ET
Health and Healthcare
Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week trading highs and…